cardiac resynchronisation therapy
Mechanisms by which cardiac resynchronisation therapy improves cardiac performance in heart failure
... in cardiac output was due to an increase in both heart rate and stroke volume (mainly due to an increase in LVEDV with a modest increase in ejection fraction) ...in cardiac output was due entirely to an ...
183
Heart failure syndrome and predicting response to cardiac resynchronisation therapy.
... augment cardiac function. Cardiac resynchronisation therapy (CRT) is proven to reverse the progression of left ventricular systolic dysfunction, the most common cause of heart ...inefficient ...
417
Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
... as cardiac resynchronisation therapy (CRT) and, more importantly, that a speci fi c measure of endothelial function, termed fl ow-mediated dilation (FMD), mea- sured a priori, can assist in the ...
9
Stress echocardiography for selecting potential responders to cardiac resynchronisation therapy.
... In the current ESC/ACC/AHA guidelines, the selection of patients for cardiac resynchronisation therapy (CRT) is based upon the QRS duration, which reflects interventricular dyssynchrony. However, ...
6
Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
... Figure 3 Receiver-operating characteristics (ROCs) curves for distinguishing patients who were event-free for the primary composite outcome 3 years after cardiac resynchronisation therapy the primary ...
8
Cardiovascular magnetic resonance in the prediction of outcome after cardiac resynchronisation therapy
... Cardiac resynchronisation therapy results in reverse remodelling. (Yu et al., 2005b) The largest study of 141 patients found that baseline variables including QRS duration, NYHA class, 6 minute walk ...
275
Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland
... of cardiac resynchronisation therapy (CRT) on long-term clinical outcomes in symptomatic heart fail- ure patients (New York Heart Association [NYHA] class II–IV) with reduced left ventricular (LV) ...
9
Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy – a pilot study
... V. A. Kuznetsov 1 , A. M. Soldatova 1* , J. D. Kasprzak 2 , D. V. Krinochkin 1 and N. N. Melnikov 1 Abstract Background: Some patients with congestive heart failure have greater improvement of cardiac remodelling ...
7
Cardiac Resynchronisation Therapy - Defibrillators (CRT-D) - Medical Devices Pipeline Assessment, 2016
... The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product ...
Body composition in heart failure and the impact of cardiac resynchronisation therapy: a proof-of-concept study
... CRT, cardiac resynchronisation therapy; eGFR, estimated glomerular filtration rate; FM, fat mass; LBBB, Left bundle branch block; LVEF, left ventricular ejection fraction; LVESV, left ventricular end ...
5
Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy : a systematic review
... CRT-d, cardiac resynchronisation therapy defibrillator; CARE-HF, cardiac resynchronisation in heart failure; LBBB, left bundle branch block; LV, left ventricular; LVESV, left ...
10
Totally epicardial cardiac resynchronisation therapy system implantation in patients with heart failure undergoing CABG description of 3 cases
... epicardial cardiac resynchronisation therapy system implantation in patients with heart failure undergoing CABG 161 P Pa attiie en ntt A Ag ge e M MII llo occa attiio on n Q QR RS S w wiid dtth h C ...
5
Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
... curves for patients dichotomised by LBBB and QRS width ≥ 150 ms were generated ( fi gure 2B, C, respect- ively). The presence of LBBB was associated with a 58% lower risk of death, transplant or LVAD (adjusted HR 0.42, ...
9
Cardiac Resynchronisation Therapy and its effects on systolic heart failure
... 39 patients with at least one VT/VF event). Therefore there was a fifteen percent reduction in the composite endpoint, which was not statistically significant (P=0.35). In terms of the other endpoints, CRT-D did improve ...
223
Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotrope-dependent heart failure patients
... of cardiac resynchronisation in a group of 11 end-stage inotrope-dependent HF ...a therapy in this group of patients, mainly because these patients commonly did not meet the inclusion criteria of the ...
6
Cardiac resynchronisation therapy in patients with end-stage heart failure long-term follow-up
... The use of CRT markedly decreased hospitalisation time of all causes as well as for HF deterioration. These findings are consistent with the observations of other authors [1-6, 8]. The number of hospitalisations in the ...
8
Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
... MEDLINE, CINAHL, Web of Science, Cochrane Central and Google Scholar were searched (inception through 30 August 2017) independently by two investigators (JA and PD) using keywords: atrial fibrillation AND cardiac ...
12
Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
... evaluating cardiac extracellular matrix biomarkers and micro- ribonucleic acid (miRNA) expression before and after CRT assessing ability to predict functional response and ...of cardiac fibrosis assessed ...
12
Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
... weeks), end-stage renal disease (on renal replacement therapy), significant cognitive impairment or terminal illness (expected survival<1 year). Postimplantation exclusions were applied in case of procedure ...
12
Utilizing FEM-Software to quantify pre- and post-interventional cardiac reconstruction data based on modelling data sets from surgical ventricular repair therapy (SVRT) and cardiac resynchronisation therapy (CRT)
... most cardiac surgical operating ...the cardiac surgeon has no sophisti- cated, immediate, quantitative analysis of the pre- and post-interventional 3D LV ...
13